158 related articles for article (PubMed ID: 31628681)
1. The diagnosis values of serum STAT4 and sEng in preeclampsia.
Zhang L; Li X; Zhou C; You Z; Zhang J; Cao G
J Clin Lab Anal; 2020 Feb; 34(2):e23073. PubMed ID: 31628681
[TBL] [Abstract][Full Text] [Related]
2. An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia.
Cim N; Kurdoglu M; Ege S; Yoruk I; Yaman G; Yildizhan R
J Matern Fetal Neonatal Med; 2017 Jul; 30(13):1602-1607. PubMed ID: 27658884
[TBL] [Abstract][Full Text] [Related]
3. Soluble Endoglin As a Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Outcomes.
Leaños-Miranda A; Navarro-Romero CS; Sillas-Pardo LJ; Ramírez-Valenzuela KL; Isordia-Salas I; Jiménez-Trejo LM
Hypertension; 2019 Oct; 74(4):991-997. PubMed ID: 31446801
[TBL] [Abstract][Full Text] [Related]
4. [Serum soluble Endoglin, plasma endothelin-1 and coagulation function in early onset severe preeclampsia with organ dysfunction].
Zhang LJ; Han YH; Han YZ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Jun; 22(6):371-4. PubMed ID: 20594474
[TBL] [Abstract][Full Text] [Related]
5. The relationship between circulating tissue transglutaminase, soluble fms-like tyrosine kinase-1, soluble endoglin and vascular endothelial growth factor in pre-eclampsia.
Cheng M; He P; Fu J
J Hum Hypertens; 2016 Dec; 30(12):788-793. PubMed ID: 27169826
[TBL] [Abstract][Full Text] [Related]
6. Maternal Serum sEndoglin and Cell-Free Fetal DNA as Probable Markers of Preeclampsia: A Study in Single Center, Egypt.
Nabiel Y; Mosbah A
Immunol Invest; 2019 Aug; 48(6):608-617. PubMed ID: 30794004
[No Abstract] [Full Text] [Related]
7. sFlt-1 and soluble endoglin concentrations in serum vs plasma in preterm preeclampsia: Are they interchangeable for biomarker studies?
Brownfoot F; Kaitu'u-Lino T; Beard S; Tong S; Hannan N
Pregnancy Hypertens; 2017 Oct; 10():18-21. PubMed ID: 29153675
[TBL] [Abstract][Full Text] [Related]
8. Potential Role of Circulating Endoglin in Hypertension via the Upregulated Expression of BMP4.
Gallardo-Vara E; Gamella-Pozuelo L; Perez-Roque L; Bartha JL; Garcia-Palmero I; Casal JI; López-Novoa JM; Pericacho M; Bernabeu C
Cells; 2020 Apr; 9(4):. PubMed ID: 32316263
[TBL] [Abstract][Full Text] [Related]
9. New highly sensitive sandwich ELISA system for soluble endoglin quantification in different biological fluids.
Smirnov IV; Gryazeva IV; Vasileva MY; Krutetskaia IY; Shashkova OA; Samoylovich MP; Stolbovaya AY; Solodovnikova NG; Zazerskaya IE; Sokolov DI; Selkov SA; Klimovich VB
Scand J Clin Lab Invest; 2018 Oct; 78(6):515-523. PubMed ID: 30270756
[TBL] [Abstract][Full Text] [Related]
10. Adipsin of the Alternative Complement Pathway Is a Potential Predictor for Preeclampsia in Early Pregnancy.
Liu M; Luo X; Xu Q; Yu H; Gao L; Zhou R; Wang T
Front Immunol; 2021; 12():702385. PubMed ID: 34671343
[TBL] [Abstract][Full Text] [Related]
11. Soluble endoglin in urine as an early-pregnancy preeclampsia marker: antenatal longitudinal feasibility study.
Nogueira Reis ZS; Pereira JB; Costa LAC; Barra JS
J Obstet Gynaecol; 2021 Jul; 41(5):693-698. PubMed ID: 32811216
[TBL] [Abstract][Full Text] [Related]
12. Soluble endoglin for the prediction of preeclampsia in a high risk cohort.
Maynard SE; Moore Simas TA; Bur L; Crawford SL; Solitro MJ; Meyer BA
Hypertens Pregnancy; 2010; 29(3):330-41. PubMed ID: 20670156
[TBL] [Abstract][Full Text] [Related]
13. First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia.
Baumann MU; Bersinger NA; Mohaupt MG; Raio L; Gerber S; Surbek DV
Am J Obstet Gynecol; 2008 Sep; 199(3):266.e1-6. PubMed ID: 18771978
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy.
Salahuddin S; Lee Y; Vadnais M; Sachs BP; Karumanchi SA; Lim KH
Am J Obstet Gynecol; 2007 Jul; 197(1):28.e1-6. PubMed ID: 17618745
[TBL] [Abstract][Full Text] [Related]
15. Plasma concentrations of soluble endoglin in the maternal circulation are associated with maternal vascular malperfusion lesions in the placenta of women with preeclampsia.
Schmella MJ; Assibey-Mensah V; Parks WT; Roberts JM; Jeyabalan A; Hubel CA; Catov JM
Placenta; 2019 Mar; 78():29-35. PubMed ID: 30955708
[TBL] [Abstract][Full Text] [Related]
16. Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion.
Stepan H; Geipel A; Schwarz F; Krämer T; Wessel N; Faber R
Am J Obstet Gynecol; 2008 Feb; 198(2):175.e1-6. PubMed ID: 18226617
[TBL] [Abstract][Full Text] [Related]
17. Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
Moore Simas TA; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Maynard SE
J Matern Fetal Neonatal Med; 2014 Jul; 27(10):1038-48. PubMed ID: 24066977
[TBL] [Abstract][Full Text] [Related]
18. Alteration of serum soluble endoglin levels after the onset of preeclampsia is more pronounced in women with early-onset.
Hirashima C; Ohkuchi A; Matsubara S; Suzuki H; Takahashi K; Usui R; Suzuki M
Hypertens Res; 2008 Aug; 31(8):1541-8. PubMed ID: 18971528
[TBL] [Abstract][Full Text] [Related]
19. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
Govender N; Naicker T; Rajakumar A; Moodley J
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
[TBL] [Abstract][Full Text] [Related]
20. Soluble endoglin and transforming growth factor-beta1 in women who subsequently developed preeclampsia.
Lim JH; Kim SY; Park SY; Lee MH; Yang JH; Kim MY; Chung JH; Lee SW; Ryu HM
Prenat Diagn; 2009 May; 29(5):471-6. PubMed ID: 19253312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
